Literature DB >> 20630372

Programs to optimize adherence in glaucoma.

Dianne Kowing1, Dawn Messer, Scott Slagle, Alyon Wasik.   

Abstract

PURPOSE: This study was designed to raise awareness of the materials, devices, and Internet resources available to improve adherence to use of medications for the treatment of glaucoma and to review new devices under development.
METHODS: A review of current indexed literature and Internet resources was conducted.
RESULTS: A variety of educational brochures, pamphlets, and fact sheets promoting adherence to ocular hypotensive medications are available through multiple organizations and are easily accessed and ordered on the Internet. Video and Web-based patient educational tools have been designed to support patient adherence to glaucoma management plans and promote open dialogue between patients and providers. Reminder and recall systems that integrate with office software can be sent to cell phones as well as e-mails and personal digital assistant (PDAs), alerting patients to upcoming appointments and reminding them to instill their drops. Bottle devices with dosing support (timers with audible and visual signals and dispensing aids) and electronic monitoring have been shown to promote adherence. New products currently under development to improve the delivery of medications include nanoparticles, punctal plugs, and contact lenses that release glaucoma medications.
CONCLUSIONS: Many educational materials, services, Internet resources, and devices are available to optometrists to encourage patient adherence to glaucoma treatment and management. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630372     DOI: 10.1016/j.optm.2009.09.021

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  5 in total

1.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

2.  A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot study.

Authors:  A M Eaton; G M Gordon; A Konowal; A Allen; M Allen; A Sgarlata; G Gao; H Wafapoor; R L Avery
Journal:  Eye (Lond)       Date:  2015-09-11       Impact factor: 3.775

3.  Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.

Authors:  Jessica A Cooke; Jason S Meyer
Journal:  Curr Ophthalmol Rep       Date:  2015-08-07

4.  Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.

Authors:  Wendi S Lambert; Brian J Carlson; Alice E van der Ende; Grace Shih; Julia N Dobish; David J Calkins; Eva Harth
Journal:  Transl Vis Sci Technol       Date:  2015-01-13       Impact factor: 3.283

5.  Novel ocular antihypertensive compounds in clinical trials.

Authors:  June Chen; Stephen A Runyan; Michael R Robinson
Journal:  Clin Ophthalmol       Date:  2011-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.